Zobrazeno 1 - 10
of 66
pro vyhledávání: '"R W, Gruessner"'
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12
Outcomes of intestinal transplants (ITx; n = 977) for pediatric patients are examined using the United Network for Organ Sharing data from 1987 to 2009. Recipients were divided into four age groups: (1)2 years of age (n = 569), (2) 2-6 years (n = 219
Publikováno v:
Clinical transplantation. 15(4)
Given the constant flux in caseload and the number of personnel available in the OR, waiting for a final XM often prolongs organ preservation time (a room available at the time a XM is started is not available when the XM is completed). Longer preser
Autor:
A, Moss, J S, Najarian, D E, Sutherland, W D, Payne, R W, Gruessner, A, Humar, R, Kandaswamy, K J, Gillingham, D L, Dunn, A J, Matas
Publikováno v:
Clinical transplants.
Between 6/1963 and 12/1998, 5,069 kidney transplants were done at the University of Minnesota. Of these, about half have been living donor, half cadaver. The majority (83%) have been primary transplants. Recipients were grouped in 6 eras based on cha
Publikováno v:
Surgery. 124(5)
Bladder drainage is the most common technique for managing the exocrine secretions of pancreaticoduodenal grafts. However, bladder drainage can cause urinary, pancreatic, and metabolic complications that may require conversion to enteric drainage. Wi
Publikováno v:
Transplantation. 66(2)
Unlike in kidney and heart transplantation, the role of pretransplant donor-specific blood transfusion (DST) has not been studied prospectively in a large animal model of bowel transplantation. We investigated the impact of portal versus systemic DST
Publikováno v:
Clinical transplantation. 12(3)
As experience with tacrolimus (FK506, Prograf) accumulates and reduced rejection rates are increasingly demonstrated, some transplant centers are adopting tacrolimus-based primary immunosuppressive regimens for their patients undergoing pancreas/kidn
Autor:
A J, Matas, L, McHugh, W D, Payne, L E, Wrenshall, D L, Dunn, R W, Gruessner, D E, Sutherland, J S, Najarian
Publikováno v:
Clinical transplantation. 12(3)
We are using a validated questionnaire (SF-36) to annually assess health-related quality of life (QOL) in kidney and pancreas-kidney transplant recipients. The SF-36 consists of eight scales to assess physical functioning, general health, and mental
Publikováno v:
Clinical transplantation. 12(3)
Gallbladder perforation is a frequent complication of acute acalculous cholecystitis (AAC), resulting in substantially increased morbidity and mortality. Two groups of patients are at increased risk for perforation: those with systemic diseases (espe
Autor:
M R, Laftavi, A C, Gruessner, B J, Bland, M, Foshager, J W, Walsh, D E, Sutherland, R W, Gruessner
Publikováno v:
Transplantation. 65(4)
The most common cause of graft failure after technically successful pancreas transplants is rejection. Laboratory parameters for detecting pancreas graft rejection are not consistently reliable and can lead to unnecessary antirejection treatment. His
Publikováno v:
Transplantation. 64(11)
Simultaneous pancreas-kidney transplantation has become a widely accepted treatment option for selected uremic patients with insulin-dependent diabetes mellitus (IDDM). Patient survival rates at 1 year exceed 90%, and rates of pancreas graft survival